General Updates

Date: August 20, 2026 Ref. No.: KDL/SE/035/2026-27 To, To, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Exchange Plaza, Plot No. C-1, Block G, 25th Floor, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (East) Dalal Street, Mumbai- 400001 Mumbai – 400051 Scrip Code: 543328 NSE Symbol: KRSNAA Dear Sir/Madam, Sub: Update under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular no.HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, and further to our letters no. KDL/SE/027/2026-27 dated August 13, 2026 and KDL/SE/032/2026-27 dated August 18, 2026, please find below the relevant information in furtherance of the same: Sr. Particulars Details 1 Type of securities proposed to be issued(viz. Warrants, each convertible into one (1) fully paid-up equity shares, convertibles) equity share of face value ₹5/- each (“Warrants” / “Equity Shares”). 2 Type of issuance (further public offering, rights Preferential issue on a private placement basis, under issue, depository receipts (ADR/GDR), qualified Section 62(1)(c) read with Section 42 of the Companies institutions placement, preferential allotment Act, 2013 and Chapter V of the SEBI (ICDR) Regulations, etc.) 2018. 3 Total number of securities proposed to be Up to 16,21,000 Warrants for the total amount of Rs. issued or total amount for which the securities 91,74,86,000/-, comprising: will be issued (approximately)  Mr. Rajendra Mutha – 75,000 Warrants for Rs. 4,24,50,000/-.  Krsnaa Diagnostics (Mumbai) Private Limited – 15,46,000 Warrants for Rs. 87,50,36,000/- 4 In case of preferential issue the listed entity shall disclose the following additional details to the stock exchange(s): a) Name of Investors Mr. Rajendra Mutha and Krsna Diagnostics (Mumbai) Private Limited b) Post allotment of securities – outcome of the The Warrants are proposed to be issued to Mr. Rajendra subscription Mutha and Krsna Diagnostics (Mumbai) Private Limited. Details of the shareholding of the Proposed Allottees in the Company, prior to and after the Preferential Issue assuming full subscription are as under: Pre-Preferential Issue Post-Allotment of shareholding percentage Warrants pursuant to the of the Proposed Allottees Preferential Issue (assuming full subscription) Mr. Rajendra Mutha – Mr. Rajendra Mutha – 24.75% 23.79% Krsna Diagnostics Krsna Diagnostics (Mumbai) Private Limited (Mumbai) Private Limited – 2.36% – 6.78% 5 Issue Price The issue price as on the relevant date i.e. August 18, 2026 determined in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 is INR 566/-. 6 Number of Investors 2 Investors:  Mr. Rajendra Mutha – 75,000 Warrants  Krsnaa Diagnostics (Mumbai) Private Limited – 15,46,000 Warrants 7 In case of convertibles -intimation on Each Warrant will be convertible into 1 (one) fully paid-up conversion of securities or on lapse of the equity share of the Company of face value of INR 5 (Indian tenure of the instrument Rupees Five), which may be exercised in one or more tranches during a period of 18 (eighteen) months commencing from the date of allotment of Warrants. You are requested to take the above information on record. Thanking you, Yours sincerely, For Krsnaa Diagnostics Limited Sujoy Sudipta Bose Company Secretary & Compliance Officer Encl: as above